Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tailoring MAPK Pathways: New Therapeutic Avenues for Treating Alzheimer’s Disease

21 Apr 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cholinesterase and Neurodegenerative Diseases
Share to Computational Drug Discovery Methods

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40257689
DOI: 10.1007/s12035-025-04919-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tailoring MAPK Pathways: New Therapeutic Avenues for Treating Alzheimer’s DiseasePMID 40257689Read ↗

The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer’s Disease: An Overview and Update on New DevelopmentsSemantic proximity Read ↗

The PI3K/Akt signaling axis in Alzheimer’s disease: a valuable target to stimulate or suppress?Semantic proximity Read ↗

Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiologySemantic proximity Read ↗

c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer’s DiseasesSemantic proximity Read ↗

MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s DiseaseSemantic proximity Read ↗

Molecular Targets in Alzheimer’s Disease: From Pathogenesis to TherapeuticsSemantic proximity Read ↗

mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesisSemantic proximity Read ↗

Therapeutic Approaches to Alzheimer’s Disease Through Modulation of NRF2Semantic proximity Read ↗

Integrated Bioinformatics Analysis to Identify Alternative Therapeutic Targets for Alzheimer’s Disease: Insights from a Synaptic Machinery PerspectiveSemantic proximity Read ↗

A Map of Alzheimer’s Disease–Signaling Pathways: A Hope for Drug Target DiscoverySemantic proximity Read ↗

Defining molecular targets to prevent Alzheimer disease.Semantic proximity Read ↗

Developing theragnostics for Alzheimer's disease: Insights from cancer treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.